| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048881393 |
| P356 | DOI | 10.1038/GT.2016.30 |
| P698 | PubMed publication ID | 26990775 |
| P2093 | author name string | T Madan | |
| H Pandit | |||
| A R Koippallil Gopalakrishnan | |||
| N Warty | |||
| S M Metkari | |||
| P2860 | cites work | Peripheral biomarkers of endometriosis: a systematic review | Q24632541 |
| Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine | Q24632756 | ||
| Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies | Q26830097 | ||
| Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases | Q27004077 | ||
| Engineering mesenchymal stem cells for regenerative medicine and drug delivery | Q27026414 | ||
| Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy | Q28082334 | ||
| Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys | Q33219678 | ||
| Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model | Q33378960 | ||
| Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model | Q33522293 | ||
| Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation | Q33713464 | ||
| Anti-angiogenic treatment strategies for the therapy of endometriosis | Q34283036 | ||
| Vascular endothelial growth factor gene polymorphisms and the risk of endometriosis: a systematic review | Q34332394 | ||
| Stem cell and endometriosis: new knowledge may be producing novel therapies | Q34769746 | ||
| Stem cells and the pathogenesis of endometriosis | Q35023781 | ||
| Matrix metalloproteinases and endometriosis | Q35199238 | ||
| Association between endometriosis and hyperprolactinemia in infertile women. | Q35589263 | ||
| Antiangiogenic therapies in endometriosis | Q36052435 | ||
| Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis | Q37575007 | ||
| Novel agents for the medical treatment of endometriosis | Q38224638 | ||
| Angiogenesis as a therapeutic target in endometriosis. | Q38247441 | ||
| Mesenchymal stem cells: potential in treatment of neurodegenerative diseases | Q38253549 | ||
| MicroRNAs and angiogenesis in endometriosis | Q38436356 | ||
| MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation | Q39356606 | ||
| Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma | Q39396206 | ||
| Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. | Q39494152 | ||
| Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model | Q39820860 | ||
| Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor I. | Q40558951 | ||
| Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. | Q40793154 | ||
| Investigation of immunomodulatory properties of human Wharton's Jelly-derived mesenchymal stem cells after lentiviral transduction. | Q42175412 | ||
| Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis | Q44301754 | ||
| Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. | Q44763476 | ||
| Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. | Q45863608 | ||
| Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma | Q45889138 | ||
| Antiangiogenesis therapy for endometriosis | Q47998790 | ||
| Improved nude mouse models for green fluorescence human endometriosis | Q50533235 | ||
| Antiangiogenic agents are effective inhibitors of endometriosis. | Q52550854 | ||
| Theories on the pathogenesis of endometriosis | Q59046724 | ||
| Elevated vascular endothelia growth factor-A in the serum and peritoneal fluid of patients with endometriosis | Q84701277 | ||
| Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype | Q86038100 | ||
| P433 | issue | 7 | |
| P921 | main subject | Adenoviridae | Q193447 |
| endometriosis | Q205764 | ||
| P304 | page(s) | 580-591 | |
| P577 | publication date | 2016-03-18 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice | |
| P478 | volume | 23 |
| Q91737511 | Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model |
| Q57169681 | Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies |
| Q40080450 | Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity |
| Q39024327 | Mesenchymal stem cells: a promising tool for targeted gene therapy of endometriosis |
| Q92423873 | Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells |
Search more.